Jazz Pharmaceuticals
JAZZ
JAZZ
477 hedge funds and large institutions have $6.96B invested in Jazz Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 182 increasing their positions, 159 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
4% less funds holding
Funds holding: 497 → 477 (-20)
18% less call options, than puts
Call options by funds: $19.5M | Put options by funds: $23.9M
22% less first-time investments, than exits
New positions opened: 53 | Existing positions closed: 68
Holders
477
Holding in Top 10
7
Calls
$19.5M
Puts
$23.9M
Top Buyers
| 1 | +$172M | |
| 2 | +$131M | |
| 3 | +$57.2M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$53M |
| 5 |
VPC
Vestal Point Capital
New York
|
+$45.2M |
Top Sellers
| 1 | -$127M | |
| 2 | -$126M | |
| 3 | -$80.1M | |
| 4 |
Morgan Stanley
New York
|
-$72.1M |
| 5 |
Millennium Management
New York
|
-$68M |